Literature DB >> 3467307

Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome.

A S Fauci.   

Abstract

A number of current issues exist that must be taken into account in the development of a strategy for dealing with the problem of the acquired immunodeficiency syndrome (AIDS) in the United States and throughout the world. Given the complexity of the problem and the fact that the epidemic is still in its evolving stages, such issues must be considered individually and as a group. The present discussion focuses on several of these critical issues and outlines approaches that might be useful in the formulation of basic scientific and public health strategies for dealing with the currently appreciated and projected problems in AIDS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467307      PMCID: PMC387121          DOI: 10.1073/pnas.83.24.9278

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

Authors:  D Zagury; J Bernard; R Leonard; R Cheynier; M Feldman; P S Sarin; R C Gallo
Journal:  Science       Date:  1986-02-21       Impact factor: 47.728

2.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

4.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

Authors:  T Folks; D M Powell; M M Lightfoote; S Benn; M A Martin; A S Fauci
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

5.  New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

Authors:  P J Kanki; F Barin; S M'Boup; J S Allan; J L Romet-Lemonne; R Marlink; M F McLane; T H Lee; B Arbeille; F Denis
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

6.  Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.

Authors:  J S McDougal; M S Kennedy; J M Sligh; S P Cort; A Mawle; J K Nicholson
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

7.  Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III.

Authors:  J N Kuritsky; S C Rastogi; G A Faich; J B Schorr; J E Menitove; R W Reilly; J R Bove
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

8.  Expression of AIDS virus envelope gene in recombinant vaccinia viruses.

Authors:  S L Hu; S G Kosowski; J M Dalrymple
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

9.  Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.

Authors:  S Chakrabarti; M Robert-Guroff; F Wong-Staal; R C Gallo; B Moss
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

10.  Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis.

Authors:  G H Friedland; B R Saltzman; M F Rogers; P A Kahl; M L Lesser; M M Mayers; R S Klein
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245

View more
  15 in total

1.  Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.

Authors:  J D Mosca; D P Bednarik; N B Raj; C A Rosen; J G Sodroski; W A Haseltine; G S Hayward; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 2.  Role of epidermal Langerhans cells in viral infections.

Authors:  E Sprecher; Y Becker
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

Authors:  R T Horvat; C Wood; N Balachandran
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.

Authors:  E Ojo-Amaize; P G Nishanian; D F Heitjan; A Rezai; I Esmail; E Korns; R Detels; J Fahey; J V Giorgi
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

5.  T lymphocytes and cervical intraepithelial neoplasia.

Authors:  M J Turner; M R Ford; M Barrett; J O White; W P Soutter
Journal:  Ir J Med Sci       Date:  1988-06       Impact factor: 1.568

6.  Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.

Authors:  S M Schnittman; S M Denning; J J Greenhouse; J S Justement; M Baseler; J Kurtzberg; B F Haynes; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.

Authors:  R L Dewar; V Natarajan; M B Vasudevachari; N P Salzman
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.

Authors:  Y Sei; P H Tsang; J P Roboz; P S Sarin; J I Wallace; J G Bekesi
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

Review 9.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Alcohol and HIV sexual risk behaviors among injection drug users.

Authors:  Kamyar Arasteh; Don C Des Jarlais; Theresa E Perlis
Journal:  Drug Alcohol Depend       Date:  2008-02-01       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.